Corporate Governance

Woman in Senior Management Positions

An appropriate representation of women in the workforce and, in particular, in leadership positions, is of utmost importance to the success of our company.

  • It is a matter of course for us to recruit well-trained, highly-qualified women, and to promote and retain them within the company
  • Overall we see a balanced diversity among our management staff with a broad range of competencies and a many different experiences as the prerequisite to our business success

In connection with the “German Act on the Equal Participation of Women and Men in Executive Positions in the Private Economy and the Public Service”, Biotest AG set target figures for the participation of women in executive positions, which are to be met by June 30, 2022.

At Biotest, an individual’s qualifications are the paramount consideration in all hiring and promotion decisions. This means that women and men with comparable qualifications and suitability have the same career opportunities. Biotest will continue to consistently act upon this principle, and will of course comply with the new law on the equal participation of women and men in executive positions.

Women on the supervisory board

The supervisory board of Biotest AG is composed of six members, four of whom represent the shareholders, and two of whom represent the employees. On June 30, 2017, two of the six representatives were women, which results in a proportion of 33%. In August 2017, the supervisory board was re-elected. The supervisory board is now composed of two women, as representatives of the shareholders, and one woman as a representative of the employees. By that proportion of 50% of the seats on the supervisory board by each men and women, the company has exceeded the statutory minimum proportion of 30% of women.

Women on the management board

In the fiscal year 2017, no women were represented in the management board. This is in line with the fixed percentage of 0%, as the management board members in office were appointed for a period beyond December 31, 2017. By June 30, 2022, the proportion of women on the management board is to increase to 25%.

Women at the first and second management level

The management board of Biotest AG has set a target figure of 20% for the participation of women at the first of management level by June 30, 2022; this means that the proportion of 16% as of June 30, 2017 is to be increased further. The target figure as of June 30, 2017 at that management level was 17%. The failure to reach the target figure mainly resulted from a lack of applications by female candidates for the vacancies. The target figure for the second management level was set at 30% by June 30, 2022. As of June 30, 2017, the proportion of women at that management level was 32%. The target figure as of June 30, 2017 at that management level was 38%. The failure to reach the target figure mainly resulted from the fact that vacancies could not be adequately filled by female executives. The targeted measures regarding the promotion of women in executive positions have, therefore, not yet had the desired effect.

The proportion of women at Biotest AG (465 female employees) as of December 31, 2017 was 41%.